- Crizotinib as a next molecularly targeted drug in non small cell lung cancer2012 | Faculty of Medicine in Pilsen
- Ceritinib - a new hope for patients with ALK-positive translocation of non-small-cell lung cancers +12015 | Faculty of Medicine in Pilsen
- First experiences with detecting ALK (anaplastic lymphoma kinase) gene rearrangement and administration of crizotinib in selected patients with non-small cell lung cancer (NSCLC)2012 | Faculty of Medicine in Pilsen
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | Second Faculty of Medicine, Third Faculty of Medicine